Thursday, December 13, 2018

Clinical presentation and survival of childhood hypertrophic cardiomyopathy: a retrospective study in United Kingdom

›
Gabrielle Norrish Ella Field Karen Mcleod Maria Ilina Graham Stuart Vinay Bhole Orhan Uzun Elspeth Brown Piers E F Daubeney Amrit Lota Katie...
Wednesday, December 12, 2018

Be open about drug failures to speed up research

›
Enrica Alteri and Lorenzo Guizzaro. Nature 563, 317-319 (2018) doi: 10.1038/d41586-018-07352-7 COMMENT 13 NOVEMBER 2018 Access to evide...
Monday, December 10, 2018

From scientific discovery to treatments for rare diseases – the view from the National Center for Advancing Translational Sciences – Office of Rare Diseases Research

›
Petra Kaufmann, Anne R. Pariser and Christopher Austin. Orphanet Journal of Rare Diseases 2018 13:196 doi:10.1186/s13023-018-0936-x We now...
Saturday, December 8, 2018

Large Interruptions of GAA Repeat Expansion Mutations in Friedreich Ataxia Are Very Rare

›
Al-Mahdawi Sahar, Ging Heather, Bayot Aurelien, Cavalcanti Francesca, La Cognata Valentina, Cavallaro Sebastiano, Giunti Paola, Pook Mark A....
Friday, December 7, 2018

Ataxia with isolated vitamin E deficiency presenting as mutation negative Friedreich’s ataxia

›
Hammans SR, Kennedy CR. Journal of Neurology, Neurosurgery & Psychiatry 1998;64:368-370. doi:10.1136/jnnp.64.3.368 Ataxia with vitamin...
Thursday, December 6, 2018

Trends in robot-assisted and virtual reality-assisted neuromuscular therapy: a systematic review of health-related multiplayer games

›
Kilian Baur, Alexandra Schättin, Eling D. de Bruin, Robert Riener, Jaime E. Duarte and Peter Wolf. Journal of NeuroEngineering and Rehabilit...
Wednesday, December 5, 2018

Federating patients identities: the case of rare diseases

›
Meriem Maaroufi, Paul Landais, Claude Messiaen, Marie-Christine Jaulent and Rémy Choquet; Orphanet Journal of Rare Diseases 2018 13:199 doi:...
Tuesday, December 4, 2018

Study of the Efficacy and Safety of Nicotinamide in Patients With Friedreich Ataxia (NICOFA)

›
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicentre Study of the Efficacy and Safety of Nicotinamide in Patients Wit...
Monday, December 3, 2018

The POWER-tool: Recommendations for involving patient representatives in choosing relevant outcome measures during rare disease clinical trial design

›
C.M.W. Gaasterland, M.C. Jansen-van der Weide, E. Vroom, K. Leeson-Beevers, M. Kaatee, R. Kaczmarek, B. Bartels, W.L. van der Pol, K.C.B. Ro...
Sunday, December 2, 2018

Impact of biobanks on research outcomes in rare diseases: a systematic review

›
Monique Garcia, Jenny Downs, Alyce Russell and Wei Wang; Orphanet Journal of Rare Diseases 2018 13:202 doi:10.1186/s13023-018-0942-z Allev...